Heart failure software manages the patient’s safety efficiently and without mounds of paperwork. It helps in spotting risks at a glance, track the patient’s journey from hospital to community. It works easily with multi-disciplinary team. It provides more time for patient care, and helps the healthcare professionals to stay informed of the patient’s condition, treatment, and the plan of management of the patient. It also gives the stored record of all monitoring activities, clinical assessment of functional capacity, weight measurement, cardiac rhythm, cognitive status, drug treatment review, and also the measurements like serum urea, electrolytes, creatinine, and estimated glomerular filtration rate. It is used to search the important patient through volumes of notes and keeping track of the periodic tests. In addition, it assimilates large amount of information quickly. It can be used in screening test results for the trends. Reviewing progress of the patient and accessing the statistical data of it can also be counted as one of the functions of the heart failure software. Some of the key benefits brought by this software are it enables shared care across multidisciplinary teams, it stores all patient information and data of the treatment at one place. It is programmed to fit the monitoring of continuous workflow. It allows the measurement of the service performance of the heart.
COVID-19 Scenario Analysis:
With the outbreak of COVID-19 globally and the stipulated lockout, there is an ongoing downturn in the healthcare market. Aside from communities, COVID-19 was equally disastrous for major world economies, especially the healthcare sector. Prominent stakeholders are continuing to adapt their strategy to the rapidly changing situation. COVID-19 is projected to have significant long-term impacts on the healthcare industry. Countries and major players would have to undertake critical healthcare changes until the crisis takes a back seat.
Technological progress, cost containment and increased access will in the near future be an integral part of healthcare reforms. Digital health and telehealth have taken a front seat in the ongoing outbreak. COVID-19 re-emphasized the importance of remote diagnosis, care and consultation. Over the past few years, regulatory and behavioural barriers have slowed Telehealth growth. However, since many healthcare providers are currently working on video conferencing and telephone calls, this segment's growth will increase several folds over the next two years. The social distancing measures also mandated online consultation of patients with moderate symptoms. In addition, it greatly reduces the burden on hospitals already swamped by counts of COVID-19 patients. Medical IoT devices that live at home with patients are now being used for optimizing outpatient treatment and minimizing repeat visits, and these devices can be further used in a crisis situation. The pandemic led to severe resource constraints. This is expected to result in the development of competitive pricing and value-based pricing models, which will accelerate the heart failure software market growth in future.
Top impacting factors: market scenario analysis, trends, drivers, impact analysis
Major factors responsible to increase the growth of the heart failure software market are rise in the demand for monitored care for individual health and change in the healthcare systems, increase in the accessibility to personal healthcare systems, various technological advancements in the software, rise in need for continuous health assessment and health awareness among the population and shifting the consumer preference toward healthy lifestyle, and increasing advancement has led to the emergence of various health monitoring devices such as remote patient monitoring device, activity tracker devices, wearable medical devices, various government and non-governments organization’s support for the development.
However, lack of awareness and knowledge among the population restraints the growth of the heart failure software market
New product launches to flourish the market
In April 2018, Zoll Medical Corporation announced that U.S. FDA approved the µCor Heart Failure and Arrhythmia Management System, a new system used to improve the management of the acute heart failure.
In August 2019, Endotronix, Inc., announced that U.S.FDA has approved the conditional investigational device exemption to begin the multi-centre PROACTIVE-HF trial of the Cordella Pulmonary Artery Pressure Sensor System.
Surge in the usage of heart failure software
Increase in the demand of the monitored care for individual health and change in the health care system can help surge the usage of the heart failure software. Moreover, rise in accessibility of the personal healthcare system drives the growth of the heart failure software market.
Key benefits of the report:
- This study presents the analytical depiction of the global heart failure software industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global heart failure software market share.
- The current market is quantitatively analyzed to highlight the global heart failure software market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the heart failure software market.
- The report provides a detailed global Heart Failure Software market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the heart failure software market research report:
- Which are the leading market players active in the heart failure software market?
- What are the current trends that will influence the heart failure software market in the next few years?
- What are the driving factors, restraints, and opportunities in the heart failure software market?
- What are the projections for the future that would help in taking further strategic steps?
Heart Failure Software Market Report Highlights
By Software type
By Delivery mode
By End user
Key Market Players
Joerns Healthcare LLC, Cerner Corporation, Handicare Group AB, SpectraCare Health System, Inc., Axis Clinical Software, others., 4S Information System Ltd., Medtronic plc., Zoll Medical Corporation, Etac AB, Citius Tech, Inc.